betapharm Arzneimittel GmbH

What betapharm Arzneimittel GmbH does

betapharm Arzneimittel GmbH is a German generic pharmaceutical manufacturer headquartered in Augsburg, founded in 1993 and operating as a wholly-owned subsidiary of Dr. Reddy's Laboratories Ltd. (Hyderabad, India) since March 2006. The company's core offering is patent-free generic medicines — both prescription (Rx) and over-the-counter (OTC) — spanning approximately 150 active ingredients in over 900 dosage forms, with a therapeutic focus on neurology, psychiatry, pain management, HIV, and oncology. Manufacturing and distribution operate under a European GMP-compliant quality management system.

The business model is B2B and sales-led. betapharm supplies community pharmacies, hospital pharmacies, and healthcare institutions across Germany through a direct sales force, pharmaceutical wholesalers, and structured partnerships with online pharmacies (including Shop-Apotheke, Besamex, DocMorris, Medikamente-per-Klick, Apodiscounter, Apotal, Sanicare, and Medpex). OTC products carry distinct 'golden wave' branding. Beyond products, betapharm operates betaCare, a patient-information service on social-law and therapy-compliance topics, and Arzneimittelsuche, an online tool for healthcare professionals and patients to retrieve product information, training materials, and package leaflets.

The company is supported by a parent-group distribution and sourcing network via Dr. Reddy's and has been expanding into digital therapeutics through a June 2025 partnership with Theranica. Compliance with the Heilmittelwerbegesetz (HWG) shapes its marketing, restricting prescription-drug content to logged-in healthcare professionals via a DocCheck portal.

Name

betapharm Arzneimittel GmbH

Legal name

betapharm Arzneimittel GmbH

Website

https://betapharm.de

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

betapharm Arzneimittel GmbH is an Augsburg-based German generic pharmaceutical manufacturer and wholly-owned subsidiary of Dr. Reddy's Laboratories, distributing approximately 150 active ingredients across 900+ dosage forms to pharmacies, hospitals, and online pharmacy partners throughout Germany.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

akta.pro secondary industries

Neurology & CNS Specialty Pharmaceuticals (HLAIACAC), Specialty Pharmacy & Biologics Distribution (CRAOAHAD)

Keywords

• Generic pharmaceuticals
• Prescription medicines
• Over-the-counter medications
• Pharmaceutical manufacturing
• Specialty generics

Headquarters

HQ city

Augsburg

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Generic Pharmaceutical Sales: Sale of patent-free generic pharmaceuticals (both prescription Rx and over-the-counter OTC products) to pharmacies, hospitals, and healthcare institutions in Germany. Revenue generated through product sales at competitive generic pricing following patent expiry of original medications.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

betapharm develops, manufactures, and distributes generic pharmaceuticals (both prescription Rx and over-the-counter OTC) in the German market, with a portfolio of approximately 150 active ingredients in over 900 dosage forms spanning therapeutic areas such as Neurology/Psychiatry, Pain, HIV, and Oncology. The company is part of the Dr. Reddy's Laboratories group and supplies community pharmacies, wholesalers, hospitals, and online pharmacy channels.

Product overview

betapharm Arzneimittel GmbH is a generic pharmaceutical company and one of the leading generic drug manufacturers in Germany. Founded in 1993 and headquartered in Augsburg, the company operates as a subsidiary of Dr. Reddy's Laboratories since 2006. The core product offering consists of generic medications (both prescription/RX and over-the-counter/OTC) spanning approximately 150 active ingredients in over 900 dosage forms, with therapeutic focuses on Neurology/Psychiatry, Pain, HIV, and Oncology. Beyond pharmaceuticals, betapharm offers betaCare—a social-medical information service providing patient guides on psychosocial and social law topics—and an online medicine search tool (Arzneimittelsuche) for product information and training materials. The company serves pharmacies, healthcare professionals, and patients through its digital platform and service offerings.

Differentiator

Problem solved

Functional benefit

Brands

• betaCare: A service providing patient information on psychosocial and social law topics including sickness benefits, reintegration, medication and co-payment regulations, rehabilitation, care, social assistance, dealing with authorities, severe disability, and disability pension.

Products and services

• Generic Pharmaceuticals (Prescription/RX) Patent-free prescription generic medications covering approximately 150 active ingredients in over 900 dosage forms, with therapeutic focus on Neurology/Psychiatry, Pain, HIV, and Oncology. Sold B2B to pharmacies, hospitals, and healthcare institutions in Germany.
• OTC Medications (Over-the-Counter) Non-prescription medications covering indications ranging from allergy (A) to zinc (Z), recognizable by the golden wave marking. Distributed via community pharmacies, pharmaceutical wholesalers, and online pharmacy partners.
• betaCare Social-medical information service providing free patient guides and support covering sick pay (Krankengeld), rehabilitation, medication and co-payment regulations, nursing care, social assistance, dealing with authorities, severe disability, and occupational disability pension. Aims to support holistic healthcare beyond medication.
• Government-approved Training Materials (Schulungsmaterial) Regulatory-compliant, government-approved training materials available as downloadable PDFs covering patient guides, physician checklists, patient cards, and safety information for specific medications such as Abacavir-Lamivudin, Ambrisentan, Bosentan, Fingolimod, Rivaroxaban, and Valproinsäure.

Quantifiable outcome

• Generics cover ~80% of pharmaceutical needs in Germany, demonstrating market importance
• +1 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• TheranicacoreGTM or Marketing Partner · 18 June 2025Strategic partnership between Dr. Reddy's subsidiary Betapharm and Theranica for digital therapeutics market collaboration. Part of broader digital therapeutics ecosystem development including collaborations between Pentec Health and Luminopia Inc., and MediBuddy and ELECOM as cited in market report.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• ALIUD PHARMA GmbH: German generics manufacturer (STADA group) covering a broad active-ingredient portfolio. Directly comparable business model with pharmacy-focused distribution and parallel focus on tenders and substitution-prone molecules.
• STADA Arzneimittel AG: German-headquartered generics and consumer healthcare company with strong European footprint. Comparable on specialty generics, OTC portfolio, and pharmacy distribution model; competes directly for shelf space and tenders.
• Hexal AG: One of the largest generic pharmaceutical manufacturers in Germany and a Sandoz (Novartis) subsidiary. Directly comparable as a German-focused generics company with broad active-ingredient portfolios serving pharmacy, hospital, and OTC channels.
• Zentiva Germany: European generics manufacturer with significant German operations. Comparable in offering affordable generic Rx and OTC products through pharmacy distribution, with similar cost-efficient positioning.
• AbZ-Pharma GmbH: German generics subsidiary focused on pharmacy-channel supply of prescription generics and self-medication. Directly comparable in distribution model and product breadth.
• ratiopharm GmbH: Teva Pharmaceutical Industries' German generics subsidiary and one of the most recognized OTC/generic brands in Germany. Closely comparable in product range, pharmacy-channel go-to-market, and OTC brand recognition.

Broad incumbents

• Viatris Inc. Global healthcare company formed by Mylan and Upjohn with significant European generic presence, including Germany. Comparable broad generics portfolio across therapeutic areas and pharmacy distribution.
• Sandoz International GmbH: Global generics leader (formerly Novartis division, now independent). Comparable in offering a broad generics portfolio including specialty generics across Germany and broader Europe, but at materially larger scale.
• Teva Pharmaceutical Industries Ltd. One of the world's largest generics manufacturers and parent of ratiopharm in Germany. Comparable at the corporate level on generics and specialty therapeutics strategy; competes broadly with betapharm in CNS and oncology.

Emerging players

• Aurobindo Pharma Deutschland: Indian-headquartered generic manufacturer with growing European/DACH footprint. Comparable on cost-efficient generics and increasing competition for German tenders and pharmacy supply.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/betapharm-arzneimittel-gmbh

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about betapharm Arzneimittel GmbH